These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23286887)

  • 21. Medical abortion for adolescents.
    Grimes DA; Raymond EG
    BMJ; 2011 Apr; 342():d2185. PubMed ID: 21508043
    [No Abstract]   [Full Text] [Related]  

  • 22. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risks of mifepristone abortion in context.
    Crockett SA
    Contraception; 2006 Aug; 74(2):174; author reply 175-6. PubMed ID: 16860057
    [No Abstract]   [Full Text] [Related]  

  • 24. Risks of mifepristone abortion in context.
    Grimes DA
    Contraception; 2006 Aug; 74(2):174-5 author reply175-6. PubMed ID: 16860058
    [No Abstract]   [Full Text] [Related]  

  • 25. Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: Worth the effort.
    Dickinson JE; Brownell P; McGinnis K; Nathan EA
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):60-4. PubMed ID: 20218999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical termination of pregnancy at 9-12 weeks of gestation.
    Vyjayanthi S; Piskorowskyj N
    J Obstet Gynaecol; 2002 Nov; 22(6):669-71. PubMed ID: 12554261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous administration of mifepristone and misoprostol for early termination of pregnancy: a randomized controlled trial.
    Goel A; Mittal S; Taneja BK; Singal N; Attri S
    Arch Gynecol Obstet; 2011 Jun; 283(6):1409-13. PubMed ID: 21431329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interruption of early pregnancy with mifepristone in combination with gemeprost.
    Sandstrøm O; Brooks L; Schantz A; Grinsted J; Grinsted L; Jacobsen JD; Nielsen SP
    Acta Obstet Gynecol Scand; 1999 Oct; 78(9):806-9. PubMed ID: 10535346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approval of mifepristone (RU 486) in Europe.
    Sitruk-Ware R
    Zentralbl Gynakol; 2000; 122(5):241-7. PubMed ID: 10857210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion.
    Liao AH; Han XJ; Wu SY; Xiao DZh; Xiong CL; Wu XR
    Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):211-6. PubMed ID: 15358467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatal infections associated with mifepristone-induced abortion.
    Greene MF
    N Engl J Med; 2005 Dec; 353(22):2317-8. PubMed ID: 16319378
    [No Abstract]   [Full Text] [Related]  

  • 32. Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol.
    Raghavan S; Comendant R; Digol I; Ungureanu S; Friptu V; Bracken H; Winikoff B
    Contraception; 2009 Feb; 79(2):84-90. PubMed ID: 19135563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing medical versus surgical termination of pregnancy at 13-20 weeks of gestation: a randomised controlled trial.
    Kelly T; Suddes J; Howel D; Hewison J; Robson S
    BJOG; 2010 Nov; 117(12):1512-20. PubMed ID: 20860598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-emptive effect of ibuprofen versus placebo on pain relief and success rates of medical abortion: a double-blind, randomized, controlled study.
    Avraham S; Gat I; Duvdevani NR; Haas J; Frenkel Y; Seidman DS
    Fertil Steril; 2012 Mar; 97(3):612-5. PubMed ID: 22265034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.
    von Hertzen H; Huong NT; Piaggio G; Bayalag M; Cabezas E; Fang AH; Gemzell-Danielsson K; Hinh ND; Mittal S; Ng EH; Chaturachinda K; Pinter B; Puscasiu L; Savardekar L; Shenoy S; Khomassuridge A; Tuyet HT; Velasco A; Peregoudov A;
    BJOG; 2010 Sep; 117(10):1186-96. PubMed ID: 20560941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Public health advisory for mifepristone.
    FDA Consum; 2005; 39(5):4-5. PubMed ID: 16421985
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical study of terminating biochemical pregnancy and early clinical pregnancy with mifepristone and misoprostol].
    Li CL; Wei M; Fu MF; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):542-5. PubMed ID: 17983494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mifepristone-induced abortion and placental complications in subsequent pregnancy.
    Zhu QX; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W
    Hum Reprod; 2009 Feb; 24(2):315-9. PubMed ID: 19054774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of mifepristone for medical abortion in Australia, 2006-2009.
    de Costa CM
    Med J Aust; 2011 Feb; 194(4):206-7. PubMed ID: 21401466
    [No Abstract]   [Full Text] [Related]  

  • 40. Toxic epidermal necrolysis after mifepristone/gemeprost-induced abortion.
    Lecorvaisier-Pieto C; Joly P; Thomine E; Tanasescu S; Noblet C; Lauret P
    J Am Acad Dermatol; 1996 Jul; 35(1):112. PubMed ID: 8682946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.